A detailed history of Moneco Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Moneco Advisors, LLC holds 3,589 shares of BSX stock, worth $300,937. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,589
Previous 3,483 3.04%
Holding current value
$300,937
Previous $238,000 15.97%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$67.33 - $77.71 $7,136 - $8,237
106 Added 3.04%
3,589 $276,000
Q1 2024

Apr 25, 2024

SELL
$57.6 - $68.62 $25,228 - $30,055
-438 Reduced 11.17%
3,483 $238,000
Q4 2023

Mar 13, 2024

BUY
$48.64 - $57.81 $826 - $982
17 Added 0.44%
3,921 $226,000
Q4 2023

Feb 05, 2024

BUY
$48.64 - $57.81 $826 - $982
17 Added 0.44%
3,908 $225,000
Q3 2023

Mar 13, 2024

SELL
$50.19 - $54.68 $200 - $218
-4 Reduced 0.1%
3,904 $206,000
Q3 2023

Nov 03, 2023

BUY
$50.19 - $54.68 $195,289 - $212,759
3,891 New
3,891 $205,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Moneco Advisors, LLC Portfolio

Follow Moneco Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneco Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneco Advisors, LLC with notifications on news.